| The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium The Lancet 379 (9822), 1214-1224, 2012 | 1075 | 2012 |
| Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data MV Holmes, CE Dale, L Zuccolo, RJ Silverwood, Y Guo, Z Ye, ... Bmj 349, g4164, 2014 | 820 | 2014 |
| HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 743 | 2015 |
| Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders M Den Hoed, M Eijgelsheim, T Esko, BJJM Brundel, DS Peal, DM Evans, ... Nature genetics 45 (6), 621-631, 2013 | 343 | 2013 |
| Secretory Phospholipase A2-IIA and Cardiovascular Disease: A Mendelian Randomization Study MV Holmes, T Simon, HJ Exeter, L Folkersen, FW Asselbergs, ... Journal of the American College of Cardiology 62 (21), 1966-1976, 2013 | 133 | 2013 |
| Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis E Nüesch, C Dale, TM Palmer, J White, BJ Keating, EP van Iperen, A Goel, ... International journal of epidemiology 45 (6), 1927-1937, 2016 | 121 | 2016 |
| Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis SH Mahmoudpour, M Leusink, L Putten, I Terreehorst, FW Asselbergs, ... Pharmacogenomics 14 (3), 249-260, 2013 | 79 | 2013 |
| Seventeen years of statin pharmacogenetics: a systematic review M Leusink, NC Onland-Moret, PIW de Bakker, A de Boer, ... Pharmacogenomics 17 (2), 163-180, 2016 | 76 | 2016 |
| Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits Nature genetics 48 (8), 867-876, 2016 | 41 | 2016 |
| Pharmacogenetic analysis of GLCCI1 in three north European pediatric asthma populations with a reported use of inhaled corticosteroids SJH Vijverberg, R Tavendale, M Leusink, L Koenderman, ... Pharmacogenomics 15 (6), 799-806, 2014 | 41 | 2014 |
| Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized … LA Donnelly, NR Van Zuydam, K Zhou, R Tavendale, F Carr, ... Pharmacogenetics and genomics 23 (10), 518-525, 2013 | 38 | 2013 |
| ST13 polymorphisms and their effect on exacerbations in steroid‐treated asthmatic children and young adults SJH Vijverberg, ES Koster, R Tavendale, M Leusink, L Koenderman, ... Clinical & experimental allergy 45 (6), 1051-1059, 2015 | 32 | 2015 |
| Genetic variation in uncontrolled childhood asthma despite ICS treatment M Leusink, SJH Vijverberg, L Koenderman, JAM Raaijmakers, ... The pharmacogenomics journal 16 (2), 158-163, 2016 | 28 | 2016 |
| A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering M Leusink, AH Maitland-Van Der Zee, B Ding, F Drenos, EPA Van Iperen, ... Pharmacogenomics 17 (6), 583-591, 2016 | 18 | 2016 |
| Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular events M Leusink, NC Onland‐Moret, FW Asselbergs, B Ding, S Kotti, ... Clinical Pharmacology & Therapeutics 95 (3), 314-320, 2014 | 18 | 2014 |
| Diverse effects of cyclic AMP variants on osteogenic and adipogenic differentiation of human mesenchymal stromal cells J Doorn, M Leusink, N Groen, J Van De Peppel, JPTM Van Leeuwen, ... Tissue Engineering Part A 18 (13-14), 1431-1442, 2012 | 16 | 2012 |
| The association between a genetic risk score for allergy and the risk of developing allergies in childhood—Results of the WHISTLER cohort A Arabkhazaeli, F Ahmadizar, M Leusink, HGM Arets, JAM Raaijmakers, ... Pediatric Allergy and Immunology 29 (1), 72-77, 2018 | 14 | 2018 |
| No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction M Leusink, CE De Keyser, NC Onland-Moret, A Hofman, LE Visser, ... Pharmacogenomics 15 (11), 1471-1477, 2014 | 13 | 2014 |
| Association claims in the sequencing era SL Pulit, M Leusink, A Menelaou, PIW De Bakker Genes 5 (1), 196-213, 2014 | 11 | 2014 |
| Toename in extramuraal opioïdgebruik in Nederland MHJ Schepens, M Leusink, SE De Vries, JA van Erkelens, H Eleveld, ... Ned Tijdschr Geneeskd 163, D3854, 2019 | 9 | 2019 |
